Orchard Therapeutics Announces Presentation of Updated Integrated Analysis of OTL-200 in MLD and Reports Progress with Newborn Screening Efforts at the 19th Annual WORLDSymposium™

February 24, 2023

https://www.globenewswire.com/news-release/2023/02/24/2615141/0/en/Orchard-Therapeutics-Announces-Presentation-of-Updated-Integrated-Analysis-of-OTL-200-in-MLD-and-Reports-Progress-with-Newborn-Screening-Efforts-at-the-19th-Annual-WORLDSymposium.html

Administration of one-time gene therapy resulted in statistically significant improvement in severe motor impairment-free survival with up to 11 years of follow-up (median 6.15 years)

Read more at globenewswire.com

Related news for (ORTX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.